Celltech, Britain's biggest biotechnology firm, today agreed to be bought by Belgium's UCB for £1.5bn. The cash deal will create Europe's second biggest bio-pharmaceutical company behind Denmark's ...

The merger of two of the UK's largest companies, Celltech (Slough, England) and Chiroscience (Cambridge, England), announced in mid-June, has brought some relief to Britain's bedraggled biotechnology ...

The directors of Celltech will share a payout of £8m as a result of the biotech group's takeover by UCB of Belgium. The directors of Celltech will share a payout of £8m as a result of the biotech ...

Celltech Group will work with Amgen Inc. on treatments for osteoporosis, a loss of bone density that can lead to fractures in elderly patients. Amgen gets marketing rights to Celltech drugs that ...

UCB said it had also agreed to license the worldwide rights for Celltech's rheumatoid arthritis treatment CDP 870. Celltech's chairman, Dr Peter Fellner, said the offer represented "fair value" for ...

LONDON (CBS.MW) -- British biotech Celltech on Tuesday agreed to be purchased by Belgian pharmaceutical UCB for $2.7 billion in cash. Celltech CLL(CCH) shares in the U.S. leapt 24.3 percent to $19.15 ...

The £1.53 ($2.25) billion agreed-on acquisition of the UK's eldest biotech company, Celltech, by the little-known Belgian drug company UCB on May 18 provides a warning that independent European ...

Celltech Group is closing down its Bothell research facility and laying off about 90 employees who work there. United Kingdom-based Celltech, which is one of the largest biotechnology companies in ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

LONDON -- British biotechntoloy firm Celltech PLC Monday said it will regain the rights to its antibody drug CDP 870 after it refused to bow to Pfizer Inc.'s demands to rework financial terms of their ...